A billionaire investor, known for his ability to buy undervalued stocks just as they begin to surge in price, has lost in his bid to control a minority stake in Yunnan's most famous brand. China's highest judiciary, the Supreme People's Court, ruled against the plaintiff earlier this week in a convoluted case involving two multinational companies, five years of confusion and billions of yuan.
At stake were 65.8 million shares issued by pharmaceutical giant Yunnan Baiyao, which Fujian businessman Chen Fashu (陈发树) claimed he first purchased in 2009. At that time, Hongta Group — one of the largest cigarette manufacturers in China — agreed to sell its 12 percent stake in Yunnan Baiyao to Chen. The sale was predicated by the state-owned tobacco giant attempting to shed non-tobacco holdings from its investment portfolio.
Upon completion of the 2.2 billion-yuan (US$356 million) purchase agreement, Chen waited for the shares to be transferred to his name. The original contract gave Hongta five days to hand over its Yunnan Baiyao stock. However, two years later, Chen still had not received them.
He filed a civil complaint in 2011, and a year later Hongta responded that it had kept the stock from Chen to "to protect [the company's] state assets from being lost". Media analysts have conjectured Hongta may have simply held on to the stock because it was appreciating so quickly. Eventually, a lower court dismissed most of Chen's claims.
Once again maintaining he had no legal possession of the Yunnan Baiyao stock, regardless of the court decision — and that his investment of 2.2 billion yuan was in a type of financial limbo — Chen appealed the finding. This week, the Supreme People's Court ruled Hongta must refund Chen's original investment with interest, but the state-owned firm will be allowed to retain its stock in Yunnan Baiyao.
Legally, Chen has run out of options and must abide by the ruling. Although he will see the return of his two-billion investment, Chen cannot be happy with the court proceedings. Yunnan Baiyao stock is currently trading at around 54 yuan per share. The company's worth has grown considerably since it diversified its product lines and expanded to overseas markets.
Chen is often called the "Warren Buffet of China" by domestic media and is worth an estimated US$2.3 billion. The nickname stems from Chen's repeated, large-scale investments in companies just before share prices skyrocket. However, in this instance, Chen's legal wranglings trumped his market savvy, causing him to miss out on what would currently amount to 1.3 billion yuan in capital gains.
Image: Sohu© Copyright 2005-2019 GoKunming.com all rights reserved. This material may not be republished, rewritten or redistributed without permission.